Skip to main content
. 2020 Jan 19;12(1):244. doi: 10.3390/cancers12010244
FDA Food and Drug Administration
FGF1 Fibroblast growth factor 1
FGF2 fibroblast growth factor 2
FGFR1 Fibroblast growth factor receptor 1
GAPDH Glyceraldehyde 3-phosphate dehydrogenase
IgG Immunoglobulin G: IHC: Immuno HistoChemistry
LATS1 Large tumor suppressor kinase 1
MDA Pca MD Anderson Prostate Cancer
MET Mesenchymal to Epithelial Transition
MST1/2 Mammalian Ste20-like kinases 1/2
NOD/SCID non-obese diabetic/severe combined immune deficiency
PBS phosphate buffered saline
PCR Polymerase chain reaction
qRT-PCR Quantitative Real-Time Polymerase Chain Reaction
RPMO Roswell Park Memorial Institute
sh-c-Met Short hairpin-C-MET
TKI Tyrosine kinase inhibitors
TBX5 T-Box Transcription Factor 5
VEGFR2 Vascular endothelial growth factor receptor 2
YAP Yes-associated protein 1